• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

As of July 2025, FDA is posting notices in a Docket at www.regulations.gov. In these cases, the link for the notices will take you to the document posted at www.regulations.gov. We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 38 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1240
Lacticaseibacillus rhamnosus ATCC PTA-126815 Jul 8, 2025 FDA has no questions (in PDF) (92 kB)
  1225
Sakura (Prunus speciosa) leaf distillate Jun 3, 2025 FDA has no questions (in PDF) (82 kB)
  1146
Nuclease enzyme preparation produced by Bacillus amyloliquefaciens expressing the gene encoding a nuclease from Serratia marcescens Jun 12, 2024 FDA has no questions (in PDF) (181 kB)
  1138
Hydroxytyrosol Sep 28, 2023 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (173 kB)
  1182
  1130
Lactobacillus rhamnosus CGMCC 21225 Sep 28, 2023 FDA has no questions (in PDF) (248 kB)
  1105
Polyglycerol polyricinoleic acid Jun 14, 2023 FDA has no questions (in PDF) (225 kB)
  1078
Bifidobacterium bifidum strain KCTC 12199BP Oct 31, 2023 FDA has no questions (in PDF) (239 kB)
  1028
Metschnikowia pulcherrima DANMET-A and M. fructicola DANMET-B Nov 21, 2022 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (306 kB)
  1021
Transglutaminase enzyme preparation produced by Streptomyces mobaraensis strain M2020197 Nov 3, 2022 FDA has no questions (in PDF) (395 kB) Jul 22, 2024
  991
Chitosanase enzyme preparation produced by Bacillus subtilis Aug 31, 2022 FDA has no questions (in PDF) (225 kB)
  978
Hydrolyzed aqueous olive pulp extract Dec 10, 2021 FDA has no questions (in PDF) (256 kB)
  970
Enzyme-modified steviol glycosides Apr 9, 2021 FDA has no questions (in PDF) (225 kB)
  907
Wheat seed oil Aug 21, 2020 FDA has no questions (in PDF) (593 kB)
  906
Wheat seed polar lipids Aug 24, 2020 FDA has no questions (in PDF) (573 kB)
  758
Lactobacillus helveticus R0052, Bifidobacterium longum subsp. infantis R0033, and Bifidobacterium bifidum R0071 Aug 20, 2018 FDA has no questions (in PDF) (103 kB)
  756
Endo-1,4-beta-glucanase from Trichoderma reesei Sep 12, 2018 FDA has no questions (in PDF) (93 kB)
  754
Algal oil (87% oleic acid) derived from Prototheca moriformis strain S6697 Jul 23, 2018 FDA has no questions (in PDF) (111 kB)
  748
Tomato powder Apr 19, 2018 At the notifier's request, FDA ceased to evaluate this notice (in PDF) (44 kB)
  730
Arachidonic-acid rich oil from Mortierella alpina strain LU 166 Mar 30, 2018 FDA has no questions (in PDF) (77 kB)
  717
Short-chain fructo-oligosaccharides Feb 13, 2018 FDA has no questions (in PDF) (82 kB) Apr 21, 2023
  673
Algal fat derived from Prototheca moriformis (S7737) Mar 27, 2017 FDA has no questions (in PDF) (76 kB)
  627
Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate Oct 11, 2016 FDA has no questions
  546
2'-O-fucosyllactose Sep 16, 2015 FDA has no questions
  529
Seed of Phalaris canariensis L. (canary seed) Jan 29, 2015 FDA has no questions
  527
Algal oil (87% oleic acid) derived from Prototheca moriformis strain S2532 Feb 6, 2015 FDA has no questions
  519
Chlorella protothecoides strain S106 flour with 40-75% protein Dec 23, 2014 FDA has no questions; some uses may require a color additive listing
  487
Dried citrus pulp Jun 6, 2014 FDA has no questions
  469
Chlorella protothecoides strain S106 flour with 40-70% lipid (algal flour)
   (Resubmission of GRN 450)
Jun 7, 2013 FDA has no questions; some uses may require a color additive listing
  450
Chlorella protothecoides S106 flour with 40-70% lipid Apr 19, 2013 At the notifier's request, FDA ceased to evaluate this notice
  469
  384
Algal oil derived from Chlorella protothecoides strain S106 (Cp algal oil) Jun 13, 2012 FDA has no questions
  327
Cruciferin-rich canola/rapeseed protein isolate and napin-rich canola/rapeseed protein isolate Aug 23, 2010 FDA has no questions
  325
Olestra Aug 30, 2010 FDA has no questions
  321
Synthetic amorphous silica
   (Resubmission of GRN 298)
Aug 18, 2010 FDA has no questions
  314
Pork protein Aug 11, 2010 FDA has no questions
  313
Beef protein Aug 11, 2010 FDA has no questions
  270
Polyglycerol polyricinoleic acid Jun 15, 2009 FDA has no questions
  259
Catechins from green tea extract
   (Resubmission of GRN 225)
Aug 21, 2009 At the notifier's request, FDA ceased to evaluate this notice
  225
Catechins from green tea extract Nov 26, 2007 At the notifier's request, FDA ceased to evaluate this notice
  259

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-